BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27701049)

  • 1. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study.
    Jyoti K; Bhatia RK; Martis EAF; Coutinho EC; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2016 Dec; 148():674-683. PubMed ID: 27701049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
    Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
    Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.
    Zhang J; Tang Q; Xu X; Li N
    Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling and cytotoxicity of diffractaic acid: HP-β-CD inclusion complex encapsulated in microspheres.
    Silva CV; Barbosa JA; Ferraz MS; Silva NH; Honda NK; Rabello MM; Hernandes MZ; Bezerra BP; Cavalcanti IM; Ayala AP; Santos NP; Santos-Magalhães NS
    Int J Biol Macromol; 2016 Nov; 92():494-503. PubMed ID: 27451026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin.
    Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K
    Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
    Nguyen MH; Yu H; Kiew TY; Hadinoto K
    Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin complexes of reduced bromonoscapine in guar gum microspheres enhance colonic drug delivery.
    Madan J; Gundala SR; Baruah B; Nagaraju M; Yates C; Turner T; Rangari V; Hamelberg D; Reid MD; Aneja R
    Mol Pharm; 2014 Dec; 11(12):4339-49. PubMed ID: 25350222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
    Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
    Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting.
    Zhang L; Cao F; Ding B; Li Q; Xi Y; Zhai G
    J Microencapsul; 2011; 28(7):659-67. PubMed ID: 21824069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.
    Lian T; Peng M; Vermorken AJ; Jin Y; Luo Z; Van de Ven WJ; Wan Y; Hou P; Cui Y
    J Nanosci Nanotechnol; 2016 Jun; 16(6):6258-64. PubMed ID: 27427699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
    Sareen R; Jain N; Rajkumari A; Dhar KL
    Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.
    Mennini N; Furlanetto S; Cirri M; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):67-75. PubMed ID: 21864681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
    Lakkakula JR; Matshaya T; Krause RW
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide/cyclodextrin complex-loaded lyophilized microparticles for intranasal application.
    Kim JE; Cho HJ; Kim DD
    Drug Dev Ind Pharm; 2014 Jun; 40(6):743-8. PubMed ID: 23547762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.